Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2022 · 10-Q
Revenue$4.45M$4.45M−8.2% vs Q1 2021 Net Income-$2.22M-$2.22MN/M vs Q1 2021 EPS Diluted-$0.02-$0.02N/M vs Q1 2021 Gross Profit$1,156,000−51.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow-$379,000N/M Free Cash Flowderived-$379,000N/M Margins · derivedGross margin26.0%−22.7 pt vs Q1 2021
Operating margin-34.1%+30.2 pt vs Q1 2021
Net margin-49.9%+14.7 pt vs Q1 2021
ended Mar 31, 2022 · filed May 16, 2022 · 46 d after period end